Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03810313
Brief Title: Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion (RAVEN)

First Submitted : January 17, 2019
First Submitted that Met QC Criteria : January 17, 2019
First Posted : January 18, 2019

Last Update Submitted that Met QC Criteria : March 12, 2021
Last Update Posted : March 16, 2021